SCHEMBL8992548

SCHEMBL8992548

COc1cccc(C(=O)C(C)N)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.64
CES2 O00748 1/20 0.62
CES1 P23141 1/20 0.62
CHRNA1 P02708 1/20 0.58
CHRNG P07510 1/20 0.58
CHRNB1 P11230 1/20 0.58
CHRNB2 P17787 1/20 0.58
SLC6A2 P23975 1/20 0.58
CHRNB4 P30926 1/20 0.58
CHRNA3 P32297 1/20 0.58
CHRNA4 P43681 1/20 0.58
SLC6A3 Q01959 1/20 0.58
CHRND Q07001 1/20 0.58
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
STS P08842 2/20 0.53
MEN1 O00255 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7427631 0.86 CES2 (0.67) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL5218170 0.86 CES2 (0.67) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL11982376 0.85 PARP1 (0.45) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL27749768 0.85 PARP1 (0.62) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL15007434 0.84 CES2 (0.65) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL20090393 0.84 CES2 (0.65) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL2599155 0.84 CES2 (0.65) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL9366959 0.83 CES2 (0.62) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL1358606 0.83 CES2 (0.62) PARP1CES2CES1CHRNA1CHRNG
SCHEMBL1164163 0.82 CES2 (0.67) PARP1CES2CES1CHRNA1CHRNG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3083986-A None JP disclosed
US-5541327-A Preparation of camptothecin analogs SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1996-07-30 US disclosed
US-5525731-A CYCLIZATION; HALOGENATION; ALKYLATION; REDUCTION; HYDROLYSIS; DECARBOXYLATION; SELENYLATION SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1996-06-11 US disclosed
EP-0471358-B1 Fluoroethylcamptothecin derivatives KYORIN SEIYAKU KK (JP) 1996-05-08 EP disclosed
US-5391745-A Cytotoxic activity towards cancer cells SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1995-02-21 US disclosed
WO-1994011376-A1 CAMPTOTHECIN ANALOGUES AND METHODS OF PREPARATION THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1994-05-26 WO disclosed
EP-0471358-A1 Fluoroethylcamptothecin derivatives KYORIN PHARMACEUTICAL CO., LTD. (JP) 1992-02-19 EP disclosed
EP-0220601-B1 PYRANOINDOLIZINE DERIVATIVES AND PREPARATION PROCESS THEREOF DAIICHI SEIYAKU CO., LTD. (JP) 1991-12-11 EP disclosed
JP-H0383986-A NEW QUINOLINE DERIVATIVE AND ITS PRODUCTION YAKULT HONSHA CO LTD 1991-04-09 JP disclosed
US-4778891-A Certain pyrano (3,4-f)-indolizine derivatives DAIICHI SEIYAKU CO., LTD. (JP) 1988-10-18 US disclosed
EP-0220601-A1 Pyranoindolizine derivatives and preparation process thereof DAIICHI SEIYAKU CO., LTD. (JP) 1987-05-06 EP disclosed